10:15 AM 392. INVITED SPEAKER.

10:45 AM 393. Therapeutic Nanocarriers Inhibit Chemotherapy-Induced Breast Cancer Metastasis. Tianyu Li, PhD, Tolulope Akinade, MD/PhD, Jie Zhou, PhD, Hongxia Wang, Qisong Tong, Siyu He, Emily Rinebold, Luis Valencia Salazar, Divya Bhansali, Yiling Zhong, Jing Ruan, Jinzhi Du, Piero Dalerba, Kam Leong, Professor, Columbia University, New york, NY, USA, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China, South China University of Technology, Guangzhou, China, Columbia University Medical Center, New York, NY, USA.

11:00 AM 394. Organotypic Breast Tumor Model Enables Drug Screening Against Tumor-Stromal Interactions. Hossein Tavana, PhD, University of Akron, Akron, OH, USA.

11:15 AM 395. Glioblastoma Spheroid Growth, Infiltration, Motility, and Chemotherapeutic Responses in Single and Dual-Stiffness Hydrogels. Shabnam Nejat, B.S., Joseph Bruns, PhD, Silviya Zustiak, PhD, Saint Louis University, Saint Louis City, MO, USA.

11:30 AM 396. Merging Biomaterials and Microscale Technologies to Engineer Ex vivo Organotypic Tumor Microenvironment (TME) Models. Mehdi Nikkhah, Arizona State University, Tempe, AZ, USA.

11:45 AM 397. Microphysiological Prostate Cancer System for in vitro Evaluation of Anti-Cancer Nanotherapeutics. Nicole Habbit, Benjamin Anbiah, Tareq Anani, PhD, Allan David, PhD, Balabhaskar Prabhakarpandian, PhD, Robert Arnold, PhD, Elizabeth Lipke, PhD, Auburn University, Auburn, AL, USA, CFD Research Corporation, Huntsville, AL, USA.

12:00 PM 398. Interrogating Matrix Determinants of Cell Migration Mode and Survival in a Tunable Tumor Stroma Mimetic. Harrison Hiraki, Daniel Matera, PhD, William Wang, PhD, Brendon Baker, PhD, University of Michigan, Ann Arbor, MI, USA.